SlideShare ist ein Scribd-Unternehmen logo
1 von 41
Regional Epidemiology
Of Hypertension
In The Gulf
Jafar Al-Said, MB. CHB. MD. FASN. FACP.
Chair of Internal Medicine.
Nephrology and Internal Medicine Consultant.
Bahrain Specialist Hospital.
1
LEARNING OBJECTIVES
• Prevalence of HTN in the Gulf region.
• Global Prevalence of HTN.
• Expected Population Growth for the coming decades.
• Health impact of other CV risk factors.
• Impact of HTN by WHO for the coming decades.
2
HTN PREVALENCE IN THE GULF
3
800%
4
UAE
9,206,000
HTN 19.1%
Yaman
23,852,000
HTN
25.1%
Bahrain
1,318,000
HTN 28%
Kuwait
3,250,000
HTN
20%
KSA
28,288,000
HTN 25.2%
Is. Rep.I
ran
76,424,000
HTN 24.3%
Iraq
32,778,000
HTN
24.4%
3,314,000
HTN 25.4%
WHO 2014 ANNUAL REPORT
TOTAL POPULATION
180,481,000
HTN 24% 45,120,250
Qatar
2,051,000
HTN 25%
5
ARE WE READY
TO TREAT
45,120, 250 X 2 = ???
HTN PATIENT IN 2050
90,240,500
6
GLOBAL PREVALENCE OF
HYPERTENSION
7
WHO REGIONAL OFFICES HTN PREVALENCE
45%
35%
41%
41% 36%
38%
HTN GLOBAL
PREVALENCE
39%
8
9
POPULATION GROWTH
10
11
Global HTN PATEINTS
39% = 2,822,891,760
12
WORLD POPULATION ESTIMATES FROM 1800 TO 2100, BASED ON "HIGH",
"MEDIUM" AND "LOW"
UNITED NATIONS PROJECTIONS IN 2010
[[FILE:WORLD-POPULATION-1800-2100.SVG|THUMB|WORLD-POPULATION-1800-
2100]]
13
14
GLOBAL PREVALENCE OF HTN IN 2100
40% of the Global population:
High UN estimated HTN
16 billion 6.4 billion
Low UN estimated
10 billion 4 billion
15
DIABETES STATISTICS
16
DIABETES PREVALENCE 2013
17
GLOBAL DIABETES PATIENTS
Year 2000 2030
DM 171,000,000
366,000,000
WHO | Country and regional data on diabetes 18
19
DM Population in the Gulf Region 2000-2030
2000 2030
4,630,000 13,772, 000
37,000
2,103,000
668,000
104,000 113,000 38,000
890,000
350,000 327,000
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
Bahrain Islamic
Republic of
Iran
Iraq Kuwait Oman Qatar Saudi
Arabia
United
Arab
Emirates
Yemen
Chart Title
2000 2030
Global DM Prevalence
20
OBESITY
21
23
HYPERLIPIDEMIA
24
25
Global 39%
Males 37%
Females 40%
CORONARY ARTERY DISEASE
26
CAUSES OF INCREASED
HYPERTENSION %
28
29
30
31
32
33
34
35
36
80% of death from CVD occur in lower and middle income
countries.
37
Mortality rates of cardiovascular diseases in
high-income and low-income Countries (age
standardized, 2008
Causes of death
2008, [Online
Database].
Geneva, WHO
2013.
38
39
ARE WE READY ????
CONCUSION AND RECOMMENDATION
• HTN effect about 25% of the Gulf Population.
• It is effecting 40% of the population around the world.
• HTN out weight all the other cardiovascular risk factors.
• Major efforts should be spent in awareness, prevention and eventually
management.
• This was the main aim behind organizing this conference. 40
REFERENCES
WHO Library Cataloguing-in-Publication Data Global status report on noncommunicable diseases
2010. 1.Chronic disease - prevention and control. 2.Chronic disease - epidemiology. 3.Chronic disease
- mortality. 4.Cost of illness. 5.Delivery of health care.. I.World Health Organization. ISBN 978 92 4
156422 9 (NLM classification: WT 500). ISBN 978 92 4 068645 8 (PDF).
Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and
control in national surveys from England, the USA and Canada, and correlation with stroke and
ischemic heart disease mortality: a cross-sectional study BMJ Open 2013;3:e003423.
doi:10.1136/bmjopen-2013-003423.
A global brief on Hypertension. Document number : WHO/DCO/WHD/2013.2. Any queries regarding
this document should be addressed to : communications@who.int.
World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014.
41

Weitere ähnliche Inhalte

Was ist angesagt?

Hypertension Prevention and Control
Hypertension Prevention and ControlHypertension Prevention and Control
Hypertension Prevention and ControlAbiodun Isah
 
Changing epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicChanging epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicGoral Gondnale Vora
 
International Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesInternational Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesJAFAR ALSAID
 
Hypertension: 2nd prevention
Hypertension: 2nd preventionHypertension: 2nd prevention
Hypertension: 2nd preventionSayed Sara
 
Hypertension among teenage years 28
Hypertension among teenage years 28Hypertension among teenage years 28
Hypertension among teenage years 28JAFAR ALSAID
 
Hypertension in elderly
Hypertension in elderlyHypertension in elderly
Hypertension in elderlyBadheeb
 
Hypertension, Diabetes and Global HEARTS
Hypertension, Diabetes and Global HEARTSHypertension, Diabetes and Global HEARTS
Hypertension, Diabetes and Global HEARTSDr Arun More
 
Macapundag, jumarly
Macapundag, jumarlyMacapundag, jumarly
Macapundag, jumarlyjumarly03
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionAbhi Manu
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery diseaseHarivansh Chopra
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionCarmela Domocmat
 
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصر
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصرProf faisal hypertension presentation فيصل الناصر, د فيصل الناصر
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصرد فيصل ال Faisal Alnasser
 
Epidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesEpidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesSarinkumar P S
 
Management of hypertension in diabetes
Management of hypertension in diabetesManagement of hypertension in diabetes
Management of hypertension in diabetesmondy19
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension managementTarek Khalil
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart diseasedrsanjeev15
 

Was ist angesagt? (20)

Hypertension
HypertensionHypertension
Hypertension
 
Hypertension Prevention and Control
Hypertension Prevention and ControlHypertension Prevention and Control
Hypertension Prevention and Control
 
Changing epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicChanging epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmic
 
International Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesInternational Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlines
 
Hypertension: 2nd prevention
Hypertension: 2nd preventionHypertension: 2nd prevention
Hypertension: 2nd prevention
 
Hypertension among teenage years 28
Hypertension among teenage years 28Hypertension among teenage years 28
Hypertension among teenage years 28
 
Hypertension in elderly
Hypertension in elderlyHypertension in elderly
Hypertension in elderly
 
Hypertension, Diabetes and Global HEARTS
Hypertension, Diabetes and Global HEARTSHypertension, Diabetes and Global HEARTS
Hypertension, Diabetes and Global HEARTS
 
Macapundag, jumarly
Macapundag, jumarlyMacapundag, jumarly
Macapundag, jumarly
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertension
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with Hypertension
 
Non c d communti
Non c d communtiNon c d communti
Non c d communti
 
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصر
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصرProf faisal hypertension presentation فيصل الناصر, د فيصل الناصر
Prof faisal hypertension presentation فيصل الناصر, د فيصل الناصر
 
Epidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesEpidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular Diseases
 
Management of hypertension in diabetes
Management of hypertension in diabetesManagement of hypertension in diabetes
Management of hypertension in diabetes
 
Cardiovascular Risk Factors and Hypertension
Cardiovascular Risk Factors and HypertensionCardiovascular Risk Factors and Hypertension
Cardiovascular Risk Factors and Hypertension
 
Hypertension lecture prof zak (1)
Hypertension lecture prof zak (1)Hypertension lecture prof zak (1)
Hypertension lecture prof zak (1)
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension management
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 

Andere mochten auch

Prevalence of ht slide
Prevalence of ht  slidePrevalence of ht  slide
Prevalence of ht slideRapp Kunjara
 
Power point exercise 1 anamarie lansangan
Power point exercise 1 anamarie lansanganPower point exercise 1 anamarie lansangan
Power point exercise 1 anamarie lansangananamarie lansangan
 
Hypertension basics 2014
Hypertension basics 2014Hypertension basics 2014
Hypertension basics 2014abualbd
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guidemeducationdotnet
 
Hypertension 2014 update
Hypertension 2014 updateHypertension 2014 update
Hypertension 2014 updateabualbd
 
Nutrition and coronary heart disease & hypertension chris kokkola
Nutrition and coronary heart disease & hypertension chris kokkolaNutrition and coronary heart disease & hypertension chris kokkola
Nutrition and coronary heart disease & hypertension chris kokkolaChris Kokkola
 
3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)KidneyOrgRu
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathysmita brahmachari
 
Essential Hypertension
Essential Hypertension Essential Hypertension
Essential Hypertension raheef
 
Management Of Hypertension in diabetes- 2009
Management Of Hypertension in diabetes- 2009Management Of Hypertension in diabetes- 2009
Management Of Hypertension in diabetes- 2009mondy19
 
Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of HypertensionMedicineAndHealthCancer
 
Fixed Dose combination ppt
Fixed Dose combination  pptFixed Dose combination  ppt
Fixed Dose combination pptKamini Sharma
 
Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Carmela Domocmat
 
hypertension : urgency and emegrency
hypertension : urgency and emegrencyhypertension : urgency and emegrency
hypertension : urgency and emegrencyTra Etty
 

Andere mochten auch (20)

Prevalence of ht slide
Prevalence of ht  slidePrevalence of ht  slide
Prevalence of ht slide
 
Power point exercise 1 anamarie lansangan
Power point exercise 1 anamarie lansanganPower point exercise 1 anamarie lansangan
Power point exercise 1 anamarie lansangan
 
Hypertension basics 2014
Hypertension basics 2014Hypertension basics 2014
Hypertension basics 2014
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guide
 
Hypertension 2014 update
Hypertension 2014 updateHypertension 2014 update
Hypertension 2014 update
 
Heart disease
Heart diseaseHeart disease
Heart disease
 
Goal Setting for Quality Improvement Process in Health Facilities
Goal Setting for Quality Improvement Process in Health FacilitiesGoal Setting for Quality Improvement Process in Health Facilities
Goal Setting for Quality Improvement Process in Health Facilities
 
Nutrition and coronary heart disease & hypertension chris kokkola
Nutrition and coronary heart disease & hypertension chris kokkolaNutrition and coronary heart disease & hypertension chris kokkola
Nutrition and coronary heart disease & hypertension chris kokkola
 
3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)
 
Hypertension
HypertensionHypertension
Hypertension
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathy
 
Essential Hypertension
Essential Hypertension Essential Hypertension
Essential Hypertension
 
Management Of Hypertension in diabetes- 2009
Management Of Hypertension in diabetes- 2009Management Of Hypertension in diabetes- 2009
Management Of Hypertension in diabetes- 2009
 
Hypertension sequel 1
Hypertension   sequel 1Hypertension   sequel 1
Hypertension sequel 1
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of Hypertension
 
Fixed Dose combination ppt
Fixed Dose combination  pptFixed Dose combination  ppt
Fixed Dose combination ppt
 
Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Formulating hypothesis in nursing research
Formulating hypothesis in nursing research
 
hypertension : urgency and emegrency
hypertension : urgency and emegrencyhypertension : urgency and emegrency
hypertension : urgency and emegrency
 
Management of Hypertension
 Management of Hypertension Management of Hypertension
Management of Hypertension
 

Ähnlich wie Regional Hypertension Epidemiology in the Gulf

Hypertension impact during the 21 centrury
Hypertension impact during the 21 centruryHypertension impact during the 21 centrury
Hypertension impact during the 21 centruryJAFAR ALSAID
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Clifford Thornton
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020PandurangChavan11
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصرAlbert Seo
 
Hypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionHypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionJAFAR ALSAID
 
Flu वह सब जो आपको FLU VACCINATION in Pregnancy के बारे में पता होना चाहिए
Flu वह सब जो आपको  FLU VACCINATION  in Pregnancy के बारे में पता होना चाहिएFlu वह सब जो आपको  FLU VACCINATION  in Pregnancy के बारे में पता होना चाहिए
Flu वह सब जो आपको FLU VACCINATION in Pregnancy के बारे में पता होना चाहिएLifecare Centre
 
NCD Prevention and Control as a Health System Strengthening Intervention
NCD Prevention and Control as a Health System Strengthening InterventionNCD Prevention and Control as a Health System Strengthening Intervention
NCD Prevention and Control as a Health System Strengthening InterventionAlbert Domingo
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health RegulationSujata Mohapatra
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptxPoojakarki10
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseasePERKI Pekanbaru
 
National guideline for Dengue (Latest) by DGHS
National guideline for Dengue (Latest) by DGHSNational guideline for Dengue (Latest) by DGHS
National guideline for Dengue (Latest) by DGHSJony Hossain
 
Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide
   Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide   Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide
Noncommunicable diseases (NCDs) account for 71% of the deaths worldwideΔρ. Γιώργος K. Κασάπης
 
Report on the work of the WHO Regional Office for Europe
Report on the work of the WHO Regional Office for EuropeReport on the work of the WHO Regional Office for Europe
Report on the work of the WHO Regional Office for EuropeWHO Regional Office for Europe
 

Ähnlich wie Regional Hypertension Epidemiology in the Gulf (20)

Hypertension impact during the 21 centrury
Hypertension impact during the 21 centruryHypertension impact during the 21 centrury
Hypertension impact during the 21 centrury
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
 
INTRODUCTION TO NCDs
INTRODUCTION TO NCDsINTRODUCTION TO NCDs
INTRODUCTION TO NCDs
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصر
 
Hypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionHypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa region
 
Flu वह सब जो आपको FLU VACCINATION in Pregnancy के बारे में पता होना चाहिए
Flu वह सब जो आपको  FLU VACCINATION  in Pregnancy के बारे में पता होना चाहिएFlu वह सब जो आपको  FLU VACCINATION  in Pregnancy के बारे में पता होना चाहिए
Flu वह सब जो आपको FLU VACCINATION in Pregnancy के बारे में पता होना चाहिए
 
NCD Prevention in Cameroon
NCD Prevention in CameroonNCD Prevention in Cameroon
NCD Prevention in Cameroon
 
Introduction of the Annual Report
Introduction of the Annual ReportIntroduction of the Annual Report
Introduction of the Annual Report
 
Non commudle desease
Non commudle deseaseNon commudle desease
Non commudle desease
 
NCD Prevention and Control as a Health System Strengthening Intervention
NCD Prevention and Control as a Health System Strengthening InterventionNCD Prevention and Control as a Health System Strengthening Intervention
NCD Prevention and Control as a Health System Strengthening Intervention
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health Regulation
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptx
 
NCD Prevention and Control, Experience in North Africa
NCD Prevention and Control, Experience in North AfricaNCD Prevention and Control, Experience in North Africa
NCD Prevention and Control, Experience in North Africa
 
5 habiba ben romdhane
5 habiba ben romdhane5 habiba ben romdhane
5 habiba ben romdhane
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart Disease
 
National guideline for Dengue (Latest) by DGHS
National guideline for Dengue (Latest) by DGHSNational guideline for Dengue (Latest) by DGHS
National guideline for Dengue (Latest) by DGHS
 
Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide
   Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide   Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide
Noncommunicable diseases (NCDs) account for 71% of the deaths worldwide
 
Unplanned art-treatment-interruptions-in-southern-africa-final-report[1]
Unplanned art-treatment-interruptions-in-southern-africa-final-report[1]Unplanned art-treatment-interruptions-in-southern-africa-final-report[1]
Unplanned art-treatment-interruptions-in-southern-africa-final-report[1]
 
Report on the work of the WHO Regional Office for Europe
Report on the work of the WHO Regional Office for EuropeReport on the work of the WHO Regional Office for Europe
Report on the work of the WHO Regional Office for Europe
 

Mehr von JAFAR ALSAID

Hypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxHypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxJAFAR ALSAID
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxJAFAR ALSAID
 
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...JAFAR ALSAID
 
Renal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxRenal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxJAFAR ALSAID
 
Ultrasound basics for Nephrologists.pptx
Ultrasound basics  for Nephrologists.pptxUltrasound basics  for Nephrologists.pptx
Ultrasound basics for Nephrologists.pptxJAFAR ALSAID
 
Uremic Leontiasis Ossea
Uremic Leontiasis OsseaUremic Leontiasis Ossea
Uremic Leontiasis OsseaJAFAR ALSAID
 
The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...JAFAR ALSAID
 
Hemodialysis catheter related infection
Hemodialysis catheter related infection Hemodialysis catheter related infection
Hemodialysis catheter related infection JAFAR ALSAID
 
Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5JAFAR ALSAID
 
Uric acid and htn saudi htn conference final 3
Uric acid and htn saudi  htn conference final 3Uric acid and htn saudi  htn conference final 3
Uric acid and htn saudi htn conference final 3JAFAR ALSAID
 
Hemodialysis orders part ii
Hemodialysis orders part iiHemodialysis orders part ii
Hemodialysis orders part iiJAFAR ALSAID
 
Hemodialysis orders part 1
Hemodialysis orders part 1Hemodialysis orders part 1
Hemodialysis orders part 1JAFAR ALSAID
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19JAFAR ALSAID
 
Hypertension and COVID-19 link
Hypertension and COVID-19 linkHypertension and COVID-19 link
Hypertension and COVID-19 linkJAFAR ALSAID
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlJAFAR ALSAID
 
HTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewHTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewJAFAR ALSAID
 
Hypertension definition 3
Hypertension definition 3Hypertension definition 3
Hypertension definition 3JAFAR ALSAID
 
Diabetic Nephropathy Review
Diabetic Nephropathy ReviewDiabetic Nephropathy Review
Diabetic Nephropathy ReviewJAFAR ALSAID
 
Central Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsCentral Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsJAFAR ALSAID
 
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...JAFAR ALSAID
 

Mehr von JAFAR ALSAID (20)

Hypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxHypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptx
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptx
 
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
 
Renal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxRenal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docx
 
Ultrasound basics for Nephrologists.pptx
Ultrasound basics  for Nephrologists.pptxUltrasound basics  for Nephrologists.pptx
Ultrasound basics for Nephrologists.pptx
 
Uremic Leontiasis Ossea
Uremic Leontiasis OsseaUremic Leontiasis Ossea
Uremic Leontiasis Ossea
 
The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...
 
Hemodialysis catheter related infection
Hemodialysis catheter related infection Hemodialysis catheter related infection
Hemodialysis catheter related infection
 
Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5
 
Uric acid and htn saudi htn conference final 3
Uric acid and htn saudi  htn conference final 3Uric acid and htn saudi  htn conference final 3
Uric acid and htn saudi htn conference final 3
 
Hemodialysis orders part ii
Hemodialysis orders part iiHemodialysis orders part ii
Hemodialysis orders part ii
 
Hemodialysis orders part 1
Hemodialysis orders part 1Hemodialysis orders part 1
Hemodialysis orders part 1
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19
 
Hypertension and COVID-19 link
Hypertension and COVID-19 linkHypertension and COVID-19 link
Hypertension and COVID-19 link
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection control
 
HTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewHTN among ESRD patients Current Review
HTN among ESRD patients Current Review
 
Hypertension definition 3
Hypertension definition 3Hypertension definition 3
Hypertension definition 3
 
Diabetic Nephropathy Review
Diabetic Nephropathy ReviewDiabetic Nephropathy Review
Diabetic Nephropathy Review
 
Central Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsCentral Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implications
 
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
 

Regional Hypertension Epidemiology in the Gulf